시간 외 거래: 1.19 -0.01 -0.83%

재규어 헬스 (JAGX)

Jaguar Health Inc 주식(JAGX)의 최신 뉴스

재규어 헬스 (JAGX)

Jaguar Health Inc 주식(JAGX)의 최신 뉴스

Jaguar Health Scientific Advisory Board Member to Share Poster Presentation at American Society of Clinical Oncology (ASCO) Quality Care Symposium About the Methodologies Involved in Designing an Advocate-Led Quality of Life Survey for Cancer Patien - AccessWire

Jaguar Health Scientific Advisory Board Member to Share Poster Presentation at American Society of Clinical Oncology (ASCO) Quality Care Symposium About the Methodologies Involved in Designing an Advocate-Led Quality of Life Survey for Cancer Patien - StockTitan

Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - Victoria Advocate

Jaguar Health to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - StockTitan

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch - BioSpace

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in... - Markets Insider

JAGXJaguar Health, Inc. Latest Stock News & Market Updates - StockTitan

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch - Quantisnow

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch - AccessWire

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch - The Lawton Constitution

Jaguar Health to Spotlight Company's Commercial Focus on Cancer Supportive Care at American Society for Radiation Oncology (ASTRO) Annual Meeting for FDA-Approved Gelclair Oral Mucositis Product in Advance of October 2024 Gelclair Launch - StockTitan

Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference - Weatherford Democrat

Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference - AccessWire

Jaguar Health to Present September 19 at the MedInvest Biotech & Pharma Investor Conference - StockTitan

Jaguar Health hires industry veteran as sales director - Investing.com

Jaguar Health hires industry veteran as sales director - Investing.com India

Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care - AccessWire

Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care - StockTitan

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - Weatherford Democrat

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - AccessWire

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - Yahoo Finance

Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - StockTitan

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - Markets Insider

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - Brazosport Facts

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - Big News Network

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - AccessWire

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs - StockTitan

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones - StockTitan

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones - Yahoo Finance

Companion Animal Health Market Report 2022: Featuring Zoetis, Jaguar Health, Elanco, Bayer, Merck & More - Yahoo Finance UK

Jaguar Health secures new patent for crofelemer in Jordan By Investing.com - Investing.com Australia

Jaguar Health secures new patent for crofelemer in Jordan By Investing.com - Investing.com Canada

Jaguar Health secures new patent for crofelemer in Jordan By Investing.com - Investing.com South Africa

Jaguar Health secures new patent for crofelemer in Jordan - Investing.com

Jaguar Health secures new patent for crofelemer in Jordan - Investing.com India

Jaguar Health secures new patent for crofelemer in Jordan By Investing.com - Investing.com UK

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) - AccessWire

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) - StockTitan

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award - Weatherford Democrat

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award - AccessWire

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award - StockTitan

Jaguar Health secures new patent for rare disease drug - Investing.com India

Jaguar Health secures new patent for rare disease drug - Investing.com

Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) - AccessWire

Issuance of New Hong Kong Patent Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) - StockTitan

Jaguar Health (HAM:1JA) Total Inventories : €8.88 Mil (As of Jun. 2024) - GuruFocus.com

JAGX (Jaguar Health) Free Cash Flow : $-29.46 Mil (TTM As of Jun. 2024) - GuruFocus.com

Jaguar Health Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

JAGX (Jaguar Health) EV-to-Revenue : 2.61 (As of Aug. 14, 2024) - GuruFocus.com

Jaguar Health, Inc. (NASDAQ:JAGX) Q2 2024 Earnings Call Transcript - Insider Monkey

Jaguar Health Reports Second Quarter 2024 Financial Results - BioSpace

Jaguar Health stock plunges to 52-week low at $1 - Investing.com

Earnings call: Jaguar Health reports revenue growth and clinical advances - Investing.com

JAGX Stock Earnings: Jaguar Health Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Jaguar Health stock plunges to 52-week low at $1 By Investing.com - Investing.com Australia

Jaguar Health stock plunges to 52-week low at $1 - Investing.com India

Why Jaguar Health (JAGX) Stock Is Down 15% - Benzinga

Jaguar Health Reports Second Quarter 2024 Financial Results - The Maryville Forum

Jaguar Health Reports Second Quarter 2024 Financial Results - StockTitan

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients - StockTitan

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients - Yahoo Finance

Jaguar Health (NASDAQ:JAGX) Stock Rating Lowered by StockNews.com - Defense World

Jaguar Health stock hits 52-week low at $1.1 amid steep decline - Investing.com

Daily Market Movement: Jaguar Health Inc (JAGX) Sees a -2.52 Decrease, Closing at 1.16 - The Dwinnex

Jaguar Health, Inc. - WDRB

Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 ResultsInvestor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Me - Yahoo Finance

JAGX과 유사한 종목